Historical Account The DPCO was first passed in 1970 and then revised in 1979, 1987 and 1995. This summary ahead tries to define the nuances of each of the acts brought in- 1947-1970 At the time of independence, most of the bulk drug was imported. Industry in India was in a nascent stage with a meagre investment of Rs. 10 crore and a production worth just Rs. 26 crore.. Till 1962, the drug industry did not have any price control. In the early 1960’s, post Chinese aggression on India the government
situation where the local manufacturing of medicines at cheaper rates is not a lucrative optionfor the local pharmaceutical industry" He argued. “Doctors are indeed involved in prescribing expensive medicines,” says Dr Shamim, “but, the onus of blame should also be put on the patient who believes in expensive drugs instead of realising that there is no difference in the active pharmaceutical ingredient.” She says that even the doctors who prefer to prescribe the generic medicine get in pressure of
I have worked for the Transportation Pharmaceutical and Medical Equipment Company (TRAPHACO) for three years. The company was founded on May 16th, 1994 with functions of production and trading of pharmaceuticals, medical supplies and equipment. On July 5th 2001 the company changed its named into TRAPHACO, for the purpose of trading in multiple industries in line with the new economic trends. On the 45-year race for the faith of health of Vietnamese people, TRAPHACO, with more than 800 employees and
LITERATURE REVIEW Narsana, B., & Mukherjee, A (2015). Issues and trends in the Indian Pharma Industry. Express Pharma: This article examines the legacy and the issues that are faced by the Indian pharmaceutical industry. The writers have covered various points in their article ranging from the growth of the Indian pharmaceutical industry to the future of the IPI. A number of ways to improve the industry for all the parties involved have been suggested, for instance, the compulsory Better patent protection
Turing pros: Reliable and efficient Turing Pharmaceuticals is a biopharmaceutical company. The offices are in New York City. Turing concentrates on developing and commercializing innovative treatments for unmet diseases and conditions for a broad range of areas that there are limited or no treatment options. Imprimis Pharmaceuticals Inc, which is a pharmaceutical company focuses on delivering high quality and innovative medicines to physicians and patients at affordable prices. Comparing two companies
of the industry? Dunning's (1993) criticism of Porter's was that it was a ‘very ethnocentric US way of looking at the world’ (Narayanan and Fahey, 2005), there is of course room for improvement in the model. Each industry has different factors that are more relevant to that particular industry than others, for example in the pharmaceutical industry we can take Regulation as a sixth force as it’s such a significant element to the industry. Regulatory compliance is vital in a pharmaceutical company
manufacture pharmaceutical formulations at Vapi, Gujarat. The Company specializes in selected therapeutic segment to psychiatry, cardiology, neurology, gastroenterology, orthopedics, ophthalmology nephrology and diabetology. It also makes Active Pharmaceutical Ingredients such as warfarin, carbamazepine, etodolac , clorazepate, anticancers, steroids, peptides, sex hormones, and controlled substances. It is the largest pharmaceutical company in India, the biggest Indian pharmaceutical company in the
CHALLENGES AND POSSIBLE PROBLEMS TO INTRODUCE CHROMOBAND AID INTO THE MARKET Financial challenge has always been a great obstacle in bringing forth new products into the market. Sufficient financial support is highly crucial to afford from the level of preliminary research, patent and clinical test, mass production and finally the commercialization of product into public. To ensure consistency of product research, efforts should be done by researcher to get funds or sponsorship from relevant governmental
PHARMACEUTICAL RISK MANAGEMENT PLAN: AN OVERVIEW Introduction: Risk management is set of Pharmacovigilance activities and intervention designed to identify, characterize, prevent or minimize risk relating to medicinal products including the assessment of effectiveness of the effectiveness of those activities and intervention. Risk assessment means identifying and characterization the nature, frequency, and severity of the risk associated with the use of product. Risk minimization means
Abstract In today economy, businesses a considerable shift in the nature of assets, income and provide a return for investors. More and more companies across a wide range of industries, such as information technology, consumer products and pharmaceutical has a tremendous value on investments in intangible assets. Investigate reports of intangible assets is the purpose of this study, the root of the Organization's success is, how the assessment and reporting of accounting. In this survey, some regulators